Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Helsinki - Delayed Quote EUR

Herantis Pharma Oyj (HRTIS.HE)

Compare
1.3750
-0.0850
(-5.82%)
At close: April 4 at 6:04:48 PM GMT+3
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
5,027
5,027
-154
7,992.7634
9,049.8280
Operating Income
-5,027
-5,027
154
-7,992.7634
-9,049.8280
Net Non Operating Interest Income Expense
87
87
125
-1,331.4619
-14,526.4067
Pretax Income
-4,940
-4,940
280
-9,324.2253
-23,576.2358
Net Income Common Stockholders
-4,940
-4,940
280
-9,324.2253
-23,576.2358
Diluted NI Available to Com Stockholders
-4,940
-4,940
280
-9,324.2253
-23,576.2358
Basic EPS
-0.24
--
0.02
-0.64
-2.31
Diluted EPS
-0.24
--
0.02
-0.64
-2.31
Basic Average Shares
20,160.7330
--
17,195.2550
14,654.1490
10,205.9010
Diluted Average Shares
20,160.7330
--
17,195.2550
14,654.1490
10,205.9010
Total Operating Income as Reported
-5,027
-5,027
154
-7,992.7634
-9,049.8280
Total Expenses
5,027
5,027
-154
7,992.7634
9,049.8280
Net Income from Continuing & Discontinued Operation
-4,940
-4,940
280
-9,324.2253
-23,576.2358
Normalized Income
-4,940
-4,940
280
-9,324.2253
-23,576.2358
Interest Income
52
52
42
0.0359
0.3093
Interest Expense
6
6
552
67.5243
14,526.7161
Net Interest Income
87
87
125
-1,331.4619
-14,526.4067
EBIT
-4,934
-4,934
832
-9,256.7010
-9,049.5197
EBITDA
-4,934
-4,934
832
-9,096.9959
-8,889.8147
Reconciled Depreciation
--
--
--
159.7052
159.7050
Net Income from Continuing Operation Net Minority Interest
-4,940
-4,940
280
-9,324.2253
-23,576.2358
Normalized EBITDA
-4,934
-4,934
832
-9,096.9959
-8,889.8147
Tax Rate for Calcs
--
--
0.0002
--
--
12/31/2021 - 6/11/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NANOFH.HE Nanoform Finland Oyj
1.0900
-7.16%
 
78D.F Alzinova AB (publ)
0.1886
+21.83%
 
FARON.HE Faron Pharmaceuticals Oy
2.4300
-2.61%
 
FARN.L Faron Pharmaceuticals Oy
215.00
+2.38%
 
VLA.PA Valneva SE
2.6140
-17.59%
 
STRO Sutro Biopharma, Inc.
0.5421
-8.51%
 
CYBN Cybin Inc.
5.69
-4.53%
 
VERV Verve Therapeutics, Inc.
3.6200
-5.85%
 
MNMD Mind Medicine (MindMed) Inc.
5.43
-2.16%
 
ATAI Atai Life Sciences N.V.
1.3100
-0.38%